Clinical Trials for Drug: AG-120

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-17-39 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation Open